C‐reactive protein and model for end‐stage liver disease score: Have we found the fifth element?

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-6473|21|6|713-715

ISSN： 1527-6465

Source： LIVER TRANSPLANTATION, Vol.21, Iss.6, 2015-06, pp. : 713-715

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adding C‐reactive protein and procalcitonin to the model of end‐stage liver disease score improves mortality prediction in patients with complications of cirrhosis

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 33, Iss. 3, 2018-03 ,pp. : 726-732

John Wiley & Sons Inc

Access to resources Recommend Favorite

Keeping high model for end‐stage liver disease score liver transplantation candidates alive

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 11, 2015-11 ,pp. : 1428-1437

John Wiley & Sons Inc

Access to resources Recommend Favorite

Outcomes for liver transplant candidates listed with low model for end‐stage liver disease score

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 11, 2015-11 ,pp. : 1403-1409

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reciprocal Association of Plasma Adiponectin and Serum C-Reactive Protein Concentration in Haemodialysis Patients with End-Stage Kidney Disease – A Follow-Up Study

By  

Nephron Clin Pract, Vol. 101, Iss. 1, 2005-05 ,pp. : c18-c24

Karger

Access to resources Recommend Favorite

MELDEQ: An alternative Model for End‐Stage Liver Disease score for patients with hepatocellular carcinoma

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 5, 2015-05 ,pp. : 612-622

John Wiley & Sons Inc

Access to resources Recommend Favorite